6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Tissue Engineering in Cosmetic Surgery
Aesthetic and reconstructive demands increasingly intersect with regenerative technologies, offering enhanced results with minimal invasiveness. Tissue engineering in cosmetic surgery incorporates scaffolds, growth factors, and autologous cells to improve skin texture, volume, and contour. Applications range from engineered dermal fillers and bioactive matrices for facial rejuvenation to cartilage scaffolds used in rhinoplasty or ear reconstruction. These techniques not only enhance cosmetic outcomes but also promote functional restoration in post-traumatic or congenital conditions. Tissue engineering in cosmetic surgery also emphasizes biocompatibility, reduced scarring, and accelerated recovery through bioengineered support systems. As patient expectations evolve, combining precision regeneration with surgical artistry is reshaping the future of aesthetic medicine.
Kunal Mitra
Florida Tech, United States
Nagy Habib
Imperial College London, United Kingdom
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Paige Derr
National Institutes of Health, United States
Aradhana Kasimsetty
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States
Lisa Martin
University Grenoble Alpes, France
Audrey Cherblanc
Healshape SAS, FranceSubmit your abstract Today
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States